Safety and Tolerability of Ferric Carboxymaltose (FCM) Versus Standard of Care in Treating Iron Deficiency Anemia
NCT00703937 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 708
Last updated 2018-02-20
Summary
The objective of this study is to evaluate the safety of FCM in patients with anemia who are not dialysis dependent.
Conditions
Interventions
- DRUG
-
Ferric Carboxymaltose (FCM)
- DRUG
-
Standard Medical Care (SMC) for the treatment of IDA
Sponsors & Collaborators
-
American Regent, Inc.
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-07-31
- Primary Completion
- 2009-07-31
- Completion
- 2011-03-31
Countries
- United States
Study Locations
More Related Trials
-
Intravenous Ferric Carboxymaltose vs IV Iron Sucrose or IV Iron Dextran in Treating Iron Deficiency Anemia in Women
NCT01290315 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Efficacy and Safety of Ferric Carboxymaltose (FCM) in Patients With Iron Deficiency Anemia and Impaired Renal Function
NCT00981045 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of the Safety and Efficacy of Intravenous Iron Versus Oral Iron in the Treatment of Anemia Secondary to Heavy Uterine Bleeding
NCT00395993 ·Status: COMPLETED ·Phase: PHASE3
-
Total Dose Infusion of Ferumoxytol(1020mg) in 15 Minutes for Iron Deficiency Anemia
NCT01374919 ·Status: COMPLETED ·Phase: NA
-
Hypophosphatemia With Ferric Carboxymaltose Vs. Iron Dextran in Iron Deficiency Secondary to Heavy Uterine Bleeding
NCT01307007 ·Status: COMPLETED ·Phase: PHASE2
-
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency / and Sub-Study
NCT03037931 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Intravenous Ferric Carboxymaltose in Pediatric Patients With Iron Deficiency Anemia and Unsatisfactory Response Oral Iron Under Study Protocol 1VIT17044
NCT04269707 ·Status: COMPLETED ·Phase: PHASE3
-
Observational Study on the Use of IV (Intravenous) Iron Therapy Among Subjects With Iron Deficiency Anemia
NCT01984554 ·Status: COMPLETED
-
A Study to Characterize the PK and PD Profile of IV FCM in Pediatric Subjects 1-17 Years Old With IDA
NCT02410213 ·Status: COMPLETED ·Phase: PHASE2
-
Incidence of Hypophosphatemia After Treatment With Iron Isomaltoside/Ferric Derisomaltose or Ferric Carboxymaltose in Subjects With Iron Deficiency Anaemia
NCT03237065 ·Status: COMPLETED ·Phase: PHASE3
-
IV Ferric Carboxymaltose Compared With Oral Iron in the Treatment of Iron Deficiency Anemia at Delivery in Tanzania
NCT02541708 ·Status: UNKNOWN ·Phase: PHASE3
-
A Study Comparing the Iron Substitution With the Medicinal Products Ferinject or Monofer
NCT02905539 ·Status: COMPLETED ·Phase: PHASE4
-
Incidence of Hypophosphatemia After Treatment With Iron Isomaltoside/Ferric Derisomaltose vs Ferric Carboxymaltose in Subjects With Iron Deficiency Anaemia
NCT03238911 ·Status: COMPLETED ·Phase: PHASE3
-
Comparative Efficacy and Safety of Intravenous Ferric Carboxymaltose (FCM) Versus Oral Iron for Iron Deficiency Anaemia in Pregnant Women
NCT01131624 ·Status: COMPLETED ·Phase: PHASE3
-
A Trial Comparing Ferumoxytol With Placebo for the Treatment of Iron Deficiency Anemia
NCT01114139 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Iron Status on Occurrence of Non-transferrin-bound Iron (NTBI) in Serum in Response to an Oral Iron Load
NCT02831712 ·Status: UNKNOWN ·Phase: NA
-
Ferric Carboxymaltose Versus Iron Sucrose for Treating Anemia in Pregnant Women
NCT06911034 ·Status: COMPLETED ·Phase: PHASE4
-
Multi-center Trial of Ferric Derisomaltose in Children 0 to <18 Years of Age With Iron Deficiency Anemia
NCT05179226 ·Status: RECRUITING ·Phase: PHASE3
-
Safety and Efficacy of a Hematinic Agent in the Treatment of Postpartum Patients
NCT00354484 ·Status: COMPLETED ·Phase: PHASE3
-
A Pilot Study Comparing Tolerance of Oral Heme Iron Polypeptide With Oral Ionic Iron
NCT01865175 ·Status: WITHDRAWN ·Phase: PHASE4
-
Intravenous Iron Isomaltoside Versus Oral Iron Supplementation for Treatment of Iron Deficiency in Pregnancy.
NCT03188445 ·Status: COMPLETED ·Phase: PHASE4
-
EFfect of Ferric Carboxymaltose on exercIse CApacity and Cardiac Function in Patients With Iron deficiencY and Chronic Heart Failure
NCT00821717 ·Status: TERMINATED ·Phase: PHASE3
-
A Study to Evaluate Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects
NCT03893045 ·Status: RECRUITING ·Phase: PHASE3
-
Evaluate the PK, Safety, Tolerability of Ferric Maltol at 3 Dosage Levels in Paediatric Subjects With Iron Deficiency
NCT03181451 ·Status: COMPLETED ·Phase: PHASE1
-
Intravenous Iron in Patients With Systolic Heart Failure and Iron Deficiency to Improve Morbidity & Mortality
NCT03036462 ·Status: COMPLETED ·Phase: PHASE4